Form 4: Hims & Hers Health COO Melissa Baird Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4
Melissa Baird, COO of Hims & Hers Health, executed stock options and sold Class A Common Stock between June 3rd and June 5th, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Melissa Baird, the Chief Operating Officer of Hims & Hers Health, Inc., filed a Form 4 detailing changes in her beneficial ownership of the company's stock.
- Between June 3rd and June 5th, 2024, Baird exercised stock options to acquire Class A Common Stock at a price of $0.40 per share.
- Concurrently, she sold portions of her Class A Common Stock holdings at prices ranging from approximately $19.50 to $21.72 per share.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2023.
- The reported transactions resulted in a net decrease in her direct holdings of Class A Common Stock, while also decreasing the number of derivative securities (stock options) she holds.
- Following these transactions, Baird directly owns 541,432 shares of Class A Common Stock.
- She also holds options to purchase 599,152 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as the transactions are part of a pre-planned trading plan and don't necessarily indicate a change in the executive's outlook on the company.
Positives
- The transactions were executed under a pre-arranged 10b5-1 trading plan, which is a legal and transparent way for insiders to sell shares.
Negatives
- The sale of shares by a key executive could be perceived negatively by some investors, although it's part of a pre-planned strategy.
Risks
- Executive stock sales, even under 10b5-1 plans, can sometimes create short-term price volatility.
Industry Context
Insider trading activity is always closely watched in the healthcare and telehealth sectors, as it can provide insights into executive sentiment regarding the company's prospects.
Comparison to Industry Standards
- Monitoring insider transactions is a common practice when evaluating companies like Teladoc Health or Amwell, as it offers a glimpse into management's confidence.
- The use of 10b5-1 plans is a standard practice among public company executives to avoid accusations of illegal insider trading.
Stakeholder Impact
- Shareholders may react to the news of insider selling, although the existence of a 10b5-1 plan mitigates potential concerns.
Key Dates
| Date | Description |
|---|---|
| 2023-11-21 | Date the Reporting Person adopted a Rule 10b5-1 trading plan |
| 2024-05-20 | Reporting person acquired 2,500 shares under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan |
| 2024-06-03 | Date of first reported transaction: stock option exercise and sale of Class A Common Stock |
| 2024-06-04 | Date of subsequent reported transaction: stock option exercise and sale of Class A Common Stock |
| 2024-06-05 | Date of final reported transaction: stock option exercise and sale of Class A Common Stock |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.